NOVARTIS
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Their mission is to discover new ways to improve and extend people's lives. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy.
NOVARTIS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1996-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.novartis.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 324 11 11
Email Addresses:
[email protected]
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Abomics
Abomics Ltd is an expert company that promotes the application of medical research to patient care.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
MedCompared
MedCompared is a health comparison site that helps you to choose your prescribed medication for the best price in the best online pharmacy.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Novartis India
Novartis India is a healthcare company that address needs and deliver better patient outcomes.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
PharmaLead
PharmaLead is a healthcare company that advises and improves pharmacies in the re-design of business processes and business operations.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-22 | Gyroscope Therapeutics | Gyroscope Therapeutics acquired by Novartis | 1.5 B USD |
| 2021-09-17 | Arctos Medical | Arctos Medical acquired by Novartis | N/A |
| 2021-06-01 | Cellerys | Cellerys acquired by Novartis | N/A |
| 2020-12-17 | Cadent Therapeutics | Cadent Therapeutics acquired by Novartis | 770 M USD |
| 2020-10-29 | Vedere Bio ll | Vedere Bio ll acquired by Novartis | 280 M USD |
| 2020-04-20 | Amblyotech | Amblyotech acquired by Novartis | N/A |
| 2019-11-24 | The Medicines Company | The Medicines Company acquired by Novartis | 9.7 B USD |
| 2019-05-09 | Xiidra | Xiidra acquired by Novartis | 1.9 B USD |
| 2018-12-21 | CellforCure | CellforCure acquired by Novartis | N/A |
| 2018-10-18 | Endocyte | Endocyte acquired by Novartis | N/A |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Novartis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Novartis investment in Series A - Aktis Oncology | 84 M USD |
| 2022-07-25 | Cleerly | Novartis investment in Series C - Cleerly | 223 M USD |
| 2022-06-22 | Alladapt Immunotherapeutics | Novartis investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2022-05-19 | Deciphex | Novartis investment in Series B - Deciphex | 11.5 M USD |
| 2022-03-04 | Klarah | Novartis investment in Grant - Klarah | 20 K USD |
| 2022-03-04 | Parrots | Novartis investment in Pre Seed Round - Parrots | 100 K USD |
| 2021-12-07 | Freenome | Novartis investment in Series D - Freenome | 300 M USD |
| 2021-12-06 | Holmusk | Novartis investment in Venture Round - Holmusk | N/A |
| 2021-12-02 | Medtech Africa | Novartis investment in Grant - Medtech Africa | 20 K USD |
| 2021-11-09 | Mekonos | Novartis investment in Series A - Mekonos | 25 M USD |
Newest Events participated
Participated in Webit Festival Europe
on 2020-06-17 as sponsor
Key Employee Changes
Official Site Inspections
http://www.novartis.com Semrush global rank: 104.19 K Semrush visits lastest month: 941 K
- Host name: 104.18.1.16
- IP address: 104.18.1.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novartis"
Novartis announces new organizational structure to accelerate …
Apr 4, 2022 · Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative …See details»
Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.See details»
Novartis announces new organizational structure - World Pharma …
Apr 5, 2022 · Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus - Innovative …See details»
People and culture - Novartis
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information. Discover how Novartis turns breakthrough science into transformative, high-value treatments.See details»
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to See details»
Novartis Plans New Organizational Structure; Targets Cost-Savings …
Apr 7, 2022 · Novartis has announced a new organizational structure and operating model with the aim of achieving cost savings of $1 billion by 2024 and changes in its executive leadership …See details»
Novartis Restructures Organization to Accelerate Growth and …
Apr 5, 2022 · Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative …See details»
Novartis announces new organizational structure to
Apr 4, 2022 · Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative …See details»
Org Chart Novartis - The Official Board
Sep 2, 2024 · Innovative Medicines @ Novartis Pharmaceutical... Novartis is followed by 810 members.See details»
Novartis unveils major re-org | Pharma Manufacturing
Apr 4, 2022 · The Swiss giant's new "simplified structure and operational set-up" will integrate the pharmaceuticals and oncology business units, creating two separate commercial organizations …See details»
Novartis Foundation
Our population health approach brings together disconnected data to create insights that help authorities understand the root causes of unequal health outcomes and find the best ways and best partners to remediate those.See details»
Novartis restructures organisation to support growth and ... - PMLiVE
Apr 4, 2022 · Novartis has revealed its plans for the launch of a new organisational structure and operating model designed to support its innovation, growth, and product development goals as …See details»
Novartis announces new organizational structure to accelerate …
Basel, April 4, 2022 — Novartis today announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and …See details»
Rob Kowalski - Chief People & Organization Officer at Novartis
As Chief People & Organization (P&O) Officer of Novartis, Rob Kowalski leads the company’s strategy to unleash the power of its more than 100,000 employees to support its long-term …See details»
About - Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are …See details»
Company overview - Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are …See details»
Novartis' global revamp to cost thousands of jobs for simpler ...
Apr 12, 2022 · Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain. The company will cut thousands of jobs worldwide as part of …See details»
Novartis Campus – Wikipedia
Der Novartis Campus ist ein Gelände im Basler Stadtteil St. Johann und der globale Hauptsitz von Novartis mit rund 8000 Mitarbeitenden. [1] Das 20 Hektar grosse Areal wurde 1996 nach der …See details»
Novartis announces new organizational structure
Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus - Innovative Medicines US and …See details»
Novartis Canada
Learn about our business, strategy and performance in 2023, and how we create sustainable value for stakeholders and society.See details»